Due to the small sample size of this study and general lack of longitudinal data about prolactin and metformin in women, we conducted a retrospective study and focused on pre-treatment prolactin levels and their association with outcomes after metformin treatment in women with insulin-resistant, overweight/obesity PCOS. The gene discussed is PRL; the disease is obesity disorder.